PsyBio Therapeutics Corp. (PSYBF)
OTCMKTS · Delayed Price · Currency is USD
0.0050
+0.0049 (4,900.01%)
Oct 17, 2025, 4:00 PM EDT
PsyBio Therapeutics Market Cap
PsyBio Therapeutics has a market cap or net worth of $133 as of October 20, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
133.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since April 23, 2021, PsyBio Therapeutics's market cap has decreased from 38.24M to 133.00, a decrease of -100.00%. That is a compound annual growth rate of -95.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 133.00 | - |
| Dec 5, 2024 | 133.00 | -99.98% |
| Dec 29, 2023 | 583.50K | -80.15% |
| Dec 30, 2022 | 2.94M | -83.74% |
| Dec 31, 2021 | 18.07M | -52.73% |
| Apr 23, 2021 | 38.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.18M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |